Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2000
03/22/2000EP0987274A1 Factor VIIa Inhibitors
03/22/2000EP0987028A1 Pharmaceutical compositions comprising Hedgehog-Proteins and their use
03/22/2000EP0986754A1 Synthetic antibiotics
03/22/2000EP0986646A1 Ubiquitin conjugation proteins
03/22/2000EP0986644A1 Production of erythropoietin by endogenous gene activation
03/22/2000EP0986642A2 Antisense nucleic acids targeting hbv
03/22/2000EP0986637A2 Ribozymes cleaving epidermal growth factor receptors
03/22/2000EP0986577A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
03/22/2000EP0986572A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
03/22/2000EP0986557A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986550A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986408A1 New medicaments based on polymers composed of methacrylamide-modified gelatin
03/22/2000EP0986400A1 Integrin ligand, human mindin
03/22/2000EP0986398A1 Method for the production of vaccines against cell surface proteins
03/22/2000EP0986397A1 Use of leptin antagonists for the treatment of diabet
03/22/2000EP0986396A1 Prion protein modulator factor (ppmf) and prion resistant animals
03/22/2000EP0986395A1 Peptide parathyroid hormone analogs
03/22/2000EP0986394A1 Anti-coagulation of blood, blood plasma or synovial fluid products
03/22/2000EP0986381A1 Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
03/22/2000EP0986312A1 Method for treating a lactic raw material containing gmp
03/22/2000EP0986309A1 Uses of oil bodies
03/22/2000EP0817792B1 Compositions for the diagnosis, prevention, and treatment of tumor progression
03/22/2000EP0669831B1 Treatment of protozoal infection with bacitracin
03/22/2000EP0598129B1 Novel tetrapeptide derivative
03/22/2000CN1248291A Phosphodiesterase 8A
03/22/2000CN1248290A Method for induction of apoptotic cell death in malignant cells, through reduction of the RB to apoptosis inducing proteins ratio
03/22/2000CN1248264A Specif pancreatic lipase inhibitors and their applications
03/22/2000CN1248177A Coated particles, method of making and using
03/22/2000CN1248170A Preparation for treatment of metabolic syndrome containing human growth hormone in combination with cortisol synthesis inhibitor
03/22/2000CN1248169A Compositions for treatment of ARDS or IRDS containing 3-(cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamide and lung surfactant
03/22/2000CN1248163A Pharmaceutical preparation comprising lyophilized lipsomes encapsulating active principle which is highly insoluble in water, and the process for preparing the said preparation
03/22/2000CN1050668C Method for early detection of septicaemia and for treatment-accompanying assessment of course of sepsis, as well as means for carrying out said method
03/22/2000CN1050632C Productive Process and use of human anti-tumour alpha type interferon and mutant thereof
03/22/2000CN1050631C Preparation for high efficiency anti-tumor gama-type interferon mutant and use thereof
03/21/2000US6040441 Isolated recombinant cdna which encodes a protein having one or more cysteine containing domains; for diagnosis and therapy
03/21/2000US6040435 Antimicrobial cationic peptides
03/21/2000US6040431 Single chain analogs of the TGF-β superfamily (morphons)
03/21/2000US6040429 Congenital heart disease proteins and products related thereto
03/21/2000US6040426 Human Th2 specific protein
03/21/2000US6040424 Protein and gene for antioxidant response
03/21/2000US6040421 Escherichia coli O157:H7 epithelial adhesion and vaccine
03/21/2000US6040328 Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
03/21/2000US6040296 Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation
03/21/2000US6040293 A microbial polypeptides with antimicrobial activity; fungicides, viricides, bactericides
03/21/2000US6040292 Methods for treating diabetes
03/21/2000US6040291 Antimicrobial peptide
03/21/2000US6040290 Antitumor agents for inhibiting the growth of adenocarcinoma cells
03/21/2000US6040187 Obtain suspension of mononuclear cells, divide suspension into two equal portions, culture portions with or without a suppressor activator, wash cells, block proliferation, add responder cells and culture; evaluate proliferation
03/21/2000US6040181 Regulation of bcl-2 gene expression
03/21/2000US6040178 Compound 8 to 30 nucleobases in length targeted to coding region or 5' untranslated region of a nucleic acid encoding a human transcription factor regulated by, and mediator of, bone morphogenic proteins; for treatment of related diseases
03/21/2000US6040174 Defective adenoviruses and corresponding complementation lines
03/21/2000US6040173 Nucleic acid encoding a novel mammalian protein associated with uncontrolled cell division
03/21/2000US6040170 Human cytomegalovirus DNA sequences
03/21/2000US6040168 Dna and amino acid sequence of protein involved in neurotransmission and neurodevelopment; for diagnosis and treatment of schizophrenia and other nervous system disorders; screening drugs
03/21/2000US6040164 Amino acid sequence of enzyme which binds to calmodulin in a calcium-dependent manner and is involved in calcium signalling; for screening agonists and antagonists
03/21/2000US6040163 Amino acid sequence which couples asparagine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040162 Amino acid sequence which couples histidine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040159 Nucleotide sequence of ribonucleotides and optionally deoxyribonucleotides with optionally modified phosphates and hydrogen bonded to itself; targeted against tumor necrosis factor; for antiarthritic agents, antisense agents, viricides
03/21/2000US6040157 Amino acid sequence; for angiogenesis inhibitors, antitumor agents, antiinflammatory agents, antiarthritic agents for rheumatoid arthritis, wound healing agents; treatment of diabetic retinopathy and psoriasis
03/21/2000US6040155 Isolated nucleic acid encoding a protease having chymotrypsin activity; viricides, fungicides, bactericides, parasiticides; treatment of herpes, leprosy, colitis, acne, hemorrhoids, corneal scarring, dental plaque, immune disorders, cancer
03/21/2000US6040148 Heat shock protein/antigen having molecular weight of about 86 kilodaltons which induces an antibody to a breakdown product in recovering patients; for immunoassay diagnosis, immunogens and bactericides with reduced side effects
03/21/2000US6040145 Potentiation of the immune response
03/21/2000US6040140 Probes for use in diagnosis of acute lymphoblastic or nonlymphoblastic leukemia
03/21/2000US6040137 Amino acid sequence of antibody which specifically binds a certain antigen linked to amino acid sequence to which a certain antibody binds; immunoassay diagnostic reagents; therapy by redirecting specificity of patient's antibodies
03/21/2000US6040133 D-enzyme compositions and methods of their use
03/21/2000US6039970 Nasal administering bioactive drugs with hyaluronic acid derivatives, dissolving in dimethyl sulfoxide, adding to mineral oil, ethyl acetate, filtration
03/21/2000US6039956 Corticotropin release inhibiting factor and methods of using same for treating behavioral symptoms in an anxiety disorder
03/21/2000US6039947 Peptides and amino acid sequences for stimulating for treatment of multiple sclerosis
03/21/2000US6039945 Administering purified prothrombinase factor to humans
03/21/2000US6039944 Modified Factor VII
03/21/2000US6039943 Removal of blood from vitreous humor of blood
03/21/2000US6039941 Live vaccine for the treatment of tumor diseases
03/21/2000US6039684 Non-lethal conditioning methods for the treatment of acquired immunodeficiency syndrome
03/21/2000CA2030518C Osteoinductive compositions
03/21/2000CA1340931C Infectious bural disease virus
03/16/2000WO2000014266A1 Recombinant human sm-11044-binding receptor protein having activity of binding to ligand and utilization thereof
03/16/2000WO2000014265A1 Enzymatic oxidative deamination process
03/16/2000WO2000014257A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof
03/16/2000WO2000014256A1 Gene therapy for treatment of cancer
03/16/2000WO2000014254A2 Component of bromelain
03/16/2000WO2000014253A1 Nucleic acids and proteins from pineapple stem
03/16/2000WO2000014251A2 Human transferase proteins
03/16/2000WO2000014248A1 Cyclic nucleotide-associated proteins
03/16/2000WO2000014245A1 Dengue viruses that are replication defective in mosquitos for use as vaccines
03/16/2000WO2000014244A2 Treatment of cervical cancer
03/16/2000WO2000014236A2 Grf analogs with increased biological potency
03/16/2000WO2000014235A1 Kunitz domain polypeptide zkun6
03/16/2000WO2000014233A1 14275 receptor, a novel g-protein coupled receptor related to the edg receptor family
03/16/2000WO2000014232A1 Hypertension associated transcription factor-1 (hatf-1) and hatf related protein 1 (hrp-1)
03/16/2000WO2000014231A1 Lim domain protein homolog
03/16/2000WO2000014228A1 Neutral amino acid transporter and gene thereof
03/16/2000WO2000014226A1 Novel protein and process for producing the same
03/16/2000WO2000014224A1 Putative genes encoding skeletal muscle voltage-gated calcium channel gamma subunits
03/16/2000WO2000014222A2 GABAB RECEPTOR SUBTYPES GABAB-R1c AND GABAB-R2 AND HETERODIMERS THEREOF
03/16/2000WO2000014220A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
03/16/2000WO2000014219A2 Peptide nucleic acid-oligoadenylate chimeric molecules
03/16/2000WO2000014215A1 Method for selecting peptides for the targeted transport of drugs and markers, and peptides discovered using said method
03/16/2000WO2000014211A1 ADENOVIRUS EXPRESSION VECTOR ENCODING THE TUMOR SUPPRESSOR GENE p16 AND A METHOD OF USING
03/16/2000WO2000014210A1 Systemic carnitine deficiency gene and utilization thereof
03/16/2000WO2000014209A1 Endothelial cell proliferation inhibitors derived from human prothrombin
1 ... 2411 2412 2413 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 2430 2431 ... 3163